"Pneumococcal Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE.
Below are MeSH descriptors whose meaning is more general than "Pneumococcal Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Pneumococcal Vaccines".
This graph shows the total number of publications written about "Pneumococcal Vaccines" by people in Harvard Catalyst Profiles by year, and whether "Pneumococcal Vaccines" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 4 | 0 | 4 |
| 2002 | 3 | 1 | 4 |
| 2003 | 3 | 0 | 3 |
| 2004 | 3 | 2 | 5 |
| 2005 | 7 | 2 | 9 |
| 2006 | 3 | 2 | 5 |
| 2007 | 6 | 3 | 9 |
| 2008 | 4 | 0 | 4 |
| 2009 | 6 | 6 | 12 |
| 2010 | 12 | 0 | 12 |
| 2011 | 11 | 6 | 17 |
| 2012 | 9 | 4 | 13 |
| 2013 | 13 | 4 | 17 |
| 2014 | 5 | 2 | 7 |
| 2015 | 18 | 1 | 19 |
| 2016 | 7 | 2 | 9 |
| 2017 | 14 | 6 | 20 |
| 2018 | 12 | 3 | 15 |
| 2019 | 7 | 3 | 10 |
| 2020 | 10 | 4 | 14 |
| 2021 | 0 | 4 | 4 |
| 2022 | 1 | 10 | 11 |
| 2023 | 1 | 2 | 3 |
| 2024 | 2 | 3 | 5 |
Below are the most recent publications written about "Pneumococcal Vaccines" by people in Profiles.
-
Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial. Vaccine. 2024 Apr 11; 42(10):2560-2571.
-
Immunization with a whole cell vaccine reduces pneumococcal nasopharyngeal density and shedding, and middle ear infection in mice. Vaccine. 2024 Mar 07; 42(7):1714-1722.
-
Antimicrobial resistance of Streptococcus pneumoniae from invasive pneumococcal diseases in Latin American countries: a systematic review and meta-analysis. Front Public Health. 2024; 12:1337276.
-
Multiple antigen presenting system (MAPS): state of the art and potential applications. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):196-204.
-
Invasive Pneumococcal Disease After 2 Decades of Pneumococcal Conjugate Vaccine Use. Pediatrics. 2024 Jan 01; 153(1).
-
Pneumonia vaccine response in individuals with Down syndrome at three specialty clinics. Am J Med Genet C Semin Med Genet. 2023 Dec; 193(4):e32070.
-
Health Care Provider Knowledge and Attitudes Regarding Adult Pneumococcal Conjugate Vaccine Recommendations - United States, September 28-October 10, 2022. MMWR Morb Mortal Wkly Rep. 2023 Sep 08; 72(36):979-984.
-
Using LASSO Regression to Estimate the Population-Level Impact of Pneumococcal Conjugate Vaccines. Am J Epidemiol. 2023 07 07; 192(7):1166-1180.
-
Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines. Expert Rev Vaccines. 2023 Jan-Dec; 22(1):118-138.
-
Effectiveness of 13-valent pneumococcal conjugate vaccine on radiological primary end-point pneumonia among cases of severe community acquired pneumonia in children: A prospective multi-site hospital-based test-negative study in Northern India. PLoS One. 2022; 17(12):e0276911.